Sustained salutary effects of oral controlled-release nitroglycerin on ventricular function in congestive heart failure

Ezra A Amsterdam, N. A. Awan, A. N. DeMaria, R. R. Miller, D. O. Williams, D. T. Mason

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The hemodynamic effects of a controlled-release preparation of original nitroglycerin (ONTG), 6.5 mg to 19.5 mg, were determined during a four hour period in 10 patients with left ventricular failure. After ONTG ingestion left ventricular filling pressure (LVFP) diminished in 20 min (23 to 17 mm Hg, p<0.01), declined maximally within one hour (15 mm Hg, p<0.001) and remained decreased (p<0.02) throughout the four hours. For the entire group no significant alterations (p>0.05) occurred in systolic blood pressure, heart rate, cardiac index (CI) and peripheral resistance (PVR). However, two subgroups were identified relative to ONTG hemodynamic response. In the four patients in whom LVFP declined but remained substantially elevated (29 to 23 mm Hg, p<0.05), CI rose (1.7 to 2.1 l/min/m 2, p<0.01) while PVR fell (2074 to 1571 dyne x s x cm -5, p<0.02). In contrast, in the six patients with LVFP reductions to 12 mm Hg or less (18 to 10 mm Hg, p<0.005), CI was unchanged (2.2, p>0.05) without alteration of PVR (1799, p>0.05). This investigation provides objective evidence of the salutary hemodynamic effects of ONTG and confirms adequate gastrointestinal absorption with attainment of pharmacologically active blood levels. Moreover, oral sustained-release nitroglycerin is shown to possess long-acting peripheral vasodilator actions of considerable value in the treatment of congestive heart failure.

Original languageEnglish (US)
Pages (from-to)19-25
Number of pages7
JournalClinical Cardiology
Volume2
Issue number1
StatePublished - 1979

Fingerprint

Ventricular Function
Nitroglycerin
Heart Failure
Hemodynamics
Ventricular Pressure
Delayed-Action Preparations
Blood Pressure
Vasodilator Agents
Vascular Resistance
Eating
Heart Rate

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Amsterdam, E. A., Awan, N. A., DeMaria, A. N., Miller, R. R., Williams, D. O., & Mason, D. T. (1979). Sustained salutary effects of oral controlled-release nitroglycerin on ventricular function in congestive heart failure. Clinical Cardiology, 2(1), 19-25.

Sustained salutary effects of oral controlled-release nitroglycerin on ventricular function in congestive heart failure. / Amsterdam, Ezra A; Awan, N. A.; DeMaria, A. N.; Miller, R. R.; Williams, D. O.; Mason, D. T.

In: Clinical Cardiology, Vol. 2, No. 1, 1979, p. 19-25.

Research output: Contribution to journalArticle

Amsterdam, Ezra A ; Awan, N. A. ; DeMaria, A. N. ; Miller, R. R. ; Williams, D. O. ; Mason, D. T. / Sustained salutary effects of oral controlled-release nitroglycerin on ventricular function in congestive heart failure. In: Clinical Cardiology. 1979 ; Vol. 2, No. 1. pp. 19-25.
@article{470f7abf9f354f1cbeff6b46d19f0f22,
title = "Sustained salutary effects of oral controlled-release nitroglycerin on ventricular function in congestive heart failure",
abstract = "The hemodynamic effects of a controlled-release preparation of original nitroglycerin (ONTG), 6.5 mg to 19.5 mg, were determined during a four hour period in 10 patients with left ventricular failure. After ONTG ingestion left ventricular filling pressure (LVFP) diminished in 20 min (23 to 17 mm Hg, p<0.01), declined maximally within one hour (15 mm Hg, p<0.001) and remained decreased (p<0.02) throughout the four hours. For the entire group no significant alterations (p>0.05) occurred in systolic blood pressure, heart rate, cardiac index (CI) and peripheral resistance (PVR). However, two subgroups were identified relative to ONTG hemodynamic response. In the four patients in whom LVFP declined but remained substantially elevated (29 to 23 mm Hg, p<0.05), CI rose (1.7 to 2.1 l/min/m 2, p<0.01) while PVR fell (2074 to 1571 dyne x s x cm -5, p<0.02). In contrast, in the six patients with LVFP reductions to 12 mm Hg or less (18 to 10 mm Hg, p<0.005), CI was unchanged (2.2, p>0.05) without alteration of PVR (1799, p>0.05). This investigation provides objective evidence of the salutary hemodynamic effects of ONTG and confirms adequate gastrointestinal absorption with attainment of pharmacologically active blood levels. Moreover, oral sustained-release nitroglycerin is shown to possess long-acting peripheral vasodilator actions of considerable value in the treatment of congestive heart failure.",
author = "Amsterdam, {Ezra A} and Awan, {N. A.} and DeMaria, {A. N.} and Miller, {R. R.} and Williams, {D. O.} and Mason, {D. T.}",
year = "1979",
language = "English (US)",
volume = "2",
pages = "19--25",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Sustained salutary effects of oral controlled-release nitroglycerin on ventricular function in congestive heart failure

AU - Amsterdam, Ezra A

AU - Awan, N. A.

AU - DeMaria, A. N.

AU - Miller, R. R.

AU - Williams, D. O.

AU - Mason, D. T.

PY - 1979

Y1 - 1979

N2 - The hemodynamic effects of a controlled-release preparation of original nitroglycerin (ONTG), 6.5 mg to 19.5 mg, were determined during a four hour period in 10 patients with left ventricular failure. After ONTG ingestion left ventricular filling pressure (LVFP) diminished in 20 min (23 to 17 mm Hg, p<0.01), declined maximally within one hour (15 mm Hg, p<0.001) and remained decreased (p<0.02) throughout the four hours. For the entire group no significant alterations (p>0.05) occurred in systolic blood pressure, heart rate, cardiac index (CI) and peripheral resistance (PVR). However, two subgroups were identified relative to ONTG hemodynamic response. In the four patients in whom LVFP declined but remained substantially elevated (29 to 23 mm Hg, p<0.05), CI rose (1.7 to 2.1 l/min/m 2, p<0.01) while PVR fell (2074 to 1571 dyne x s x cm -5, p<0.02). In contrast, in the six patients with LVFP reductions to 12 mm Hg or less (18 to 10 mm Hg, p<0.005), CI was unchanged (2.2, p>0.05) without alteration of PVR (1799, p>0.05). This investigation provides objective evidence of the salutary hemodynamic effects of ONTG and confirms adequate gastrointestinal absorption with attainment of pharmacologically active blood levels. Moreover, oral sustained-release nitroglycerin is shown to possess long-acting peripheral vasodilator actions of considerable value in the treatment of congestive heart failure.

AB - The hemodynamic effects of a controlled-release preparation of original nitroglycerin (ONTG), 6.5 mg to 19.5 mg, were determined during a four hour period in 10 patients with left ventricular failure. After ONTG ingestion left ventricular filling pressure (LVFP) diminished in 20 min (23 to 17 mm Hg, p<0.01), declined maximally within one hour (15 mm Hg, p<0.001) and remained decreased (p<0.02) throughout the four hours. For the entire group no significant alterations (p>0.05) occurred in systolic blood pressure, heart rate, cardiac index (CI) and peripheral resistance (PVR). However, two subgroups were identified relative to ONTG hemodynamic response. In the four patients in whom LVFP declined but remained substantially elevated (29 to 23 mm Hg, p<0.05), CI rose (1.7 to 2.1 l/min/m 2, p<0.01) while PVR fell (2074 to 1571 dyne x s x cm -5, p<0.02). In contrast, in the six patients with LVFP reductions to 12 mm Hg or less (18 to 10 mm Hg, p<0.005), CI was unchanged (2.2, p>0.05) without alteration of PVR (1799, p>0.05). This investigation provides objective evidence of the salutary hemodynamic effects of ONTG and confirms adequate gastrointestinal absorption with attainment of pharmacologically active blood levels. Moreover, oral sustained-release nitroglycerin is shown to possess long-acting peripheral vasodilator actions of considerable value in the treatment of congestive heart failure.

UR - http://www.scopus.com/inward/record.url?scp=0018775335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018775335&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 19

EP - 25

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 1

ER -